Professor Ooi Eng Eong. - The Straits Times/Asian News Network
SINGAPORE, July 26 (The Straits Times/ANN): Human trials for a Covid-19 vaccine could begin in Singapore as early as this week.
The trial will involve 108 healthy volunteers of various ages in Singapore who will be injected with the vaccine developed by Duke-NUS Medical School and United States pharmaceutical company Arcturus Therapeutics.
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
